PRKN and neoplasm: Prior studies assessing resections of primary TNBC tissues have associated PDJ amplification with increased tumor size, frequent lymph node involvement and advanced disease (Stages 3–4), and reduced progression free survival (PFS) and overall survival (OS)29,30.